Baader Bank Aktiengesellschaft’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,900
Closed -$2.63M 533
2025
Q4
$2.63M Buy
+10,900
New +$2.79M 0.18% 96
2025
Q3
Sell
-10,600
Closed -$2.73M 590
2025
Q2
$2.73M Sell
10,600
-10,600
-50% -$2.53M 0.2% 105
2025
Q1
$4.75M Sell
21,200
-9,800
-32% -$2.29M 0.36% 89
2024
Q4
$7.09M Sell
31,000
-5,000
-14% -$1.2M 0.46% 69
2024
Q3
$8.79M Hold
36,000
0.51% 61
2024
Q2
$6.89M Buy
+36,000
New +$7.3M 0.44% 78

Other funds holding RMD

Baader Bank Aktiengesellschaft's RMD Position: Q2 2026 in Review

Baader Bank Aktiengesellschaft sold out of ResMed (RMD) in Q2 2026, closing a stake of 4,768 shares — an estimated $1.04M sold.

Baader Bank Aktiengesellschaft first reported a position in RMD in Q3 2023 and held it in 11 quarters. The position peaked at $9.14M in Q3 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Baader Bank Aktiengesellschaft reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 4,768 ResMed shares in Q2 2026, an estimated $1.04M.
  • Baader Bank Aktiengesellschaft first reported a position in ResMed in Q3 2023 and held it in 11 quarters.
  • Baader Bank Aktiengesellschaft's ResMed position peaked at $9.14M in Q3 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q2 2026, filed 23 Jul 2026.